CTEV logo

CLARITEV CORP

CTEVNYSE
πŸ† #3177 by market capEarnings Nov 5US Equity
$21.64β–Ό $0.80 (βˆ’3.69%)
πŸŒ… Pre-market$21.63β–Ό 0.05%Regular close Β· extended-hours price shown
πŸ””
Track CTEV
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.7%
7dβ–Ό 14.1%
14dβ–Ό 35.8%
30dβ–Ό 45.7%
ytdβ–Ό 49.5%
1yβ–Ό 59.3%
🏦Market Cap
$369M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+3.7%
Slowing
πŸ“ŠGross Margin
44.3%
Healthy
πŸ’΅FCF Margin
-1.8%
Thin
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$21.40 – $21.97
52-Week Range
$11.50 – $73.68
Volume
$3.00B
Avg Volume
$3.84B
Shares Outstanding
17.0M
Next Earnings
Oct 31, 2026

Fundamentals Snapshot

Annual Revenue
$965M
Last Q Revenue
$257M
P/E Ratio
-1.3
P/S Ratio
0.4x
EPS (TTM)
$-16.69
Dividend Yield
0.00%
Dilution (1yr)
+1.8%

Why Investors Own CTEV

  • βœ“High-growth profile β€” revenue up +45.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 55% gross margin and 13% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CTEV logo

CLARITEV CORP

CTEV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$965Mβ–² +3.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
27.6%β–Ό βˆ’62.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$45Mβ–Ό βˆ’103.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$12Mβ–² +16.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
16.4Mβ–² +1.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$4.6Bβ–Ό βˆ’$91M YoY
StockOtter Β· stockotter.space

About CLARITEV CORP

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologiesβ€”including descriptive, predictive, and prescriptive analyticsβ€”to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Ratings

β“˜
Consensus
Buy
12 analysts
Strong Buy4
Buy6
Hold2
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

Defense WorldΒ·7d ago

Claritev (NYSE:CTEV) CFO Douglas Michael Garis Sells 9,025 Shares

Claritev (NYSE: CTEV - Get Free Report) CFO Douglas Garis sold 9,025 shares of the firm's stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $30.59, for a total tran

Business WireΒ·8d ago

Claritev Selected by GDIT to Support CDC's World Trade Center Health Program

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #GDIT--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been se

Defense WorldΒ·9d ago

Claritev (NYSE:CTEV) Receives Consensus Rating of β€œModerate Buy” from Brokerages

Claritev (NYSE: CTEV - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a s

GuruFocusΒ·12d ago

Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100

On September 17, 2026, Claritev Corp (CTEV) shares fell 5.5%, bringing the current price to $31.73. The stock has experienced a significant decline, with a rang

Business WireΒ·13d ago

Claritev Releases 2025 Corporate Responsibility Report

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CommunityImpact--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 C

Seeking AlphaΒ·14d ago

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript